Stanford University
Showing 26,881-26,900 of 35,037 Results
-
Amitoj Singh
Ph.D. Student in Stem Cell Biology and Regenerative Medicine, admitted Autumn 2024
BioAmitoj is a PhD student studying Stem Cell Biology at the Stanford University School of Medicine. He is interested in pursuing research projects in the field of cardiovascular medicine and regenerative therapeutics.
-
Sam Sax
Lecturer, Immersion in the Arts: Living in Culture
BioSam Sax is a writer, performer, and educator currently serving as an ITALIC Lecturer at Stanford University. They're the author of Yr Dead (a novel), Long listed for the National Book Award, and Pig named one of the best books of 2023 by New York Magazine and Electric Lit. They're also the author of Madness, winner of The National Poetry Series and ‘Bury It’ winner of the James Laughlin Award from the Academy of American Poets. They're the two time Bay Area Grand Slam Champion with poems published in The New York Times, Poetry Magazine, Granta and elsewhere. Sam's received fellowships from The National Endowment for the Arts, MacDowell, The Poetry Foundation, and a Wallace Stegner Fellowship from Stanford University.
-
Anjali Bhatt Saxena, MD FASN
Clinical Professor (Affiliated), Medicine - Med/Nephrology
BioDr. Anjali Bhatt Saxena, MD is a Clinical Professor of Medicine (Affiliated) at Stanford University School of Medicine and the Director of Peritoneal Dialysis at the Santa Clara Valley Medical Center in San Jose, California. She has served as the Medical Director for an independent Peritoneal Dialysis (PD) Clinic in San Jose, CA since 2004, overseeing a large Peritoneal Dialysis clinic.
Dr. Saxena's clinical and research interests are in the area of home dialysis, including Peritoneal Dialysis and Home Hemodialysis. She is devoted to sharing her home dialysis expertise through research and education worldwide. She has been a key faculty member of Home Dialysis University (HDU) since 2007, providing home dialysis education to hundreds of US Nephrology Fellows and Nephrologists at all levels of experience; in 2024 she became HDU Program Director. She serves on the ASN Home Dialysis Steering Committee and is a founding member of the International Home Dialysis Consortium (ISN-ISPD). She has delivered numerous invited lectures at international meetings and has published scholarly work on PD in various peer-reviewed journals. Dr. Saxena is dedicated to the growth of PD worldwide; she is the immediate past-Treasurer for the International Society for Peritoneal Dialysis (ISPD) and Past-President of the N. American Chapter of ISPD. She is an Educational Ambassador for the ISN, and with colleagues supported the growth of PD in low income areas of Sri Lanka. -
Parnika Prashasti Saxena
Clinical Professor, Psychiatry and Behavioral Sciences
BioParnika Saxena is board certified in general and geriatric psychiatry. She completed her residency at St Elizabeth's Medical Center (affiliated with Tufts University School of Medicine) in Massachusetts and a clinical geriatric fellowship at the University of California, Los Angeles. She also worked as a research fellow in Clinical Psychopharmacology at Mclean Hospital (affiliated with Harvard Medical School) and also completed a psychoanalytic psychotherapy fellowship from the Boston Psychoanalytic Society and Institute. Her primary research interests lie in pharmacological and interventional treatments for resistant depression. At Stanford, she works on the inpatient service, outpatient geropsychiatry clinic and the electroconvulsive therapy service. She also serves at the program director of the Geriatric Psychiatry Fellowship. In addition to her clinical and research interests, she is passionate about patient advocacy and promoting mental health legislative changes to benefit patient care and has testified in state senate hearings to that end as a physician representative of organizations like the Northern California Psychiatric Association and American Psychiatric Association.
-
Nazish Sayed MD, PhD
Associate Professor (Research) of Surgery (Vascular Surgery)
Current Research and Scholarly InterestsThe Sayed Laboratory investigates how endothelial dysfunction contributes to cardiovascular disease and leverages human stem cell technologies to identify novel therapeutic strategies. Our research integrates patient-derived induced pluripotent stem cells (iPSCs), engineered cardiac tissues, organoids, human biospecimens, and multi-omic technologies to uncover mechanisms underlying inherited and acquired cardiovascular diseases.
A major focus of the laboratory is understanding endothelial–cardiomyocyte communication in cardiomyopathy. Using patient-specific iPSCs, human cardiac organoids, engineered heart tissues, spatial transcriptomics, and single-cell multi-omics, we study how endothelial dysfunction drives myocardial fibrosis, inflammation, and heart failure. Current efforts include investigations into LMNA-related dilated cardiomyopathy, endothelial-to-mesenchymal transition (EndoMT), and mechanisms of fibrotic remodeling.
A second major area of research is cardio-oncology. The laboratory develops human disease models to understand cardiovascular complications associated with cancer therapies, including tyrosine kinase inhibitors and immune checkpoint inhibitors. These studies have identified novel vascular mechanisms underlying treatment-related hypertension, cardiomyopathy, and heart failure.
The laboratory also investigates cardiovascular aging, toxic environmental exposures, rare vascular diseases, and regenerative medicine. By integrating human tissues, advanced stem cell models, genome engineering, spatial biology, and artificial intelligence–enabled multi-omic analyses, our goal is to develop precision therapeutic strategies that improve cardiovascular health and patient outcomes.
